Results 21 to 30 of about 735,853 (255)

Rabies: an evidence-based approach to management

South African Family Practice, 2007
Human rabies in South Africa is largely due to infection with the classical rabies virus (genotype 1), with the yellow mongoose the commonest vector except in KwaZulu-Natal, Eastern Cape, Mpumalanga and now Limpopo provinces where the dog is ...
L. Blumberg, J. Weyer, J. Frean, G.A. Ogunbanjo   +3 more
doaj   +1 more source

Isolation and complete genome sequencing of rabies virus strain isolated from a brown bear (Ursus arctos) that attacked a human in Primorsky krai (November, 2014)

Вопросы вирусологии, 2016
An attack of a brown bear (Ursus arctos) on human was detected in November, 2014 in the Barabash village (Khasan region of the Primorski krai) located in close proximity to the national park Land of the Leopard. The bear was shot. The deviant behavior of
M. Yu. Shchelkanov, A. A. Deviatkin, V. Yu. Ananiev, E. V. Frolov, I. E. Dombrovskaya, V. G. Dedkov, A. V. Ardashev, S. A. Kolomeets, I. P. Korotkova, E. N. Lyubchenko, V. V. Bandeev, M. N. Prosyannikova, I. V. Galkina, E. S. Ivanushko, N. P. Emelyanova, N. I. Baranov, S. A. Ulyanova, S. V. Aramilev, P. V. Fomenko, A. L. Surovy, N. A. Poroshin, N. N. Sokol, D. V. Maslov, E. E. Makhinya, G. A. Shipulin   +24 more
doaj   +1 more source

Alpha‐1‐antitrypsin genotyping with mouthwash specimens [PDF]

European Respiratory Journal, 2001
α1‐antitrypsin (α1‐AT) deficiency is diagnosed as a two-stage procedure (concentration and phenotype). However the latter does not provide clues to the presence of null genes without family studies and obtaining blood from patients at a distance often proves difficult.
R A, Stockley, E J, Campbell
openaire   +2 more sources

Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness

Журнал инфектологии, 2015
Genotype 1 HCV treatment in Russia assume as bitherapy (pegylated interferon – PG plus ribavirin – RBV) as three therapy based on HCV protease inhibitor such as telaprevir (TLV), boceprevir (BCV) or simeprevir (SMV) plus PG/RBV.
A. V. Rudakova, D. A. Gusev, A. N. Uskov, Yu. V. Lobzin   +3 more
doaj   +1 more source

Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: There is scarcity of data in literature regarding the treatment response with Sofosbuvir (SOF) based therapy in Indian patients with chronic Hepatitis-C Virus (HCV) infection.
Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania   +4 more
doaj   +1 more source

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE

Журнал инфектологии, 2018
Interferon-free therapy for genotype 1 hepatitis C is highly effective at any severity of liver fibrosis. The purpose of work was to assess cost-effectiveness and the budget impact of paritaprevir/ombitasvir/dasabuvir/ ritonavir (PTV/OBV/DSV/r ...
A. V. Rudakova, D. A. Gusev, A. N. Uskov, I. V. Shestakova, Yu. V. Lobzin   +4 more
doaj   +1 more source

Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects. [PDF]

PLoS ONE, 2014
BACKGROUND: Hepatitis C Virus (HCV) infection is a global health burden particularly in Egypt, where HCV genotype 4a (GT-4a) predominates. The prevention and control of HCV infection will remain a challenge until the development of an effective vaccine ...
Iman F Galal, Zainab Zakaria, Walaa R Allam, Mohamed A Mahmoud, Ahmed R Ezzat, Ahmed Osman, Imam Waked, G Thomas Strickland, Sayed F Abdelwahab   +8 more
doaj   +1 more source

Accuracy of the TRUGENEHIV-1Genotyping Kit [PDF]

Journal of Clinical Microbiology, 2003
ABSTRACTDrug resistance and poor virological responses are associated with well-characterized mutations in the viral reading frames that encode the proteins that are targeted by currently available antiretroviral drugs. An integrated system was developed that includes target gene amplification, DNA sequencing chemistry (TRUGENEHIV-1Genotyping Kit), and
Grant, Robert M., Kuritzkes, Daniel R., Johnson, Victoria A., Mellors, John W., Sullivan, John L., Swanstrom, Ronald I., D'Aquila, Richard T., Van Gorder, Mark, Holodniy, Mark, Lloyd, Robert M. Jr., Reid, Caroline, Morgan, Gillian F., Winslow, Dean L.   +12 more
openaire   +3 more sources

Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients

Journal of the Formosan Medical Association, 2016
While new direct-acting antiviral therapies for hepatitis C virus (HCV) are the standard of care, interferon-α (IFN-α) remains a standard therapy in Taiwan based on its low cost and high response rate to IFN-α-based therapy.
Chuan-Mo Lee, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Yi-Hao Yen   +6 more
doaj   +1 more source

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome. [PDF]

PLoS ONE, 2013
The correlation of neutralizing antibodies to treatment outcome in patients with chronic hepatitis C virus (HCV) infection has not been established.
Jannie Pedersen, Tanja B Jensen, Thomas H R Carlsen, Kristian Schønning, Peer Brehm Christensen, Alex Lund Laursen, Henrik Krarup, Jens Bukh, Nina Weis   +8 more
doaj   +1 more source